Search results
Author(s):
Theofanis George Korovesis
,
Paraskevi Koutrolou-Sotiropoulou
,
Demosthenes G Katritsis
Added:
1 year ago
Author(s):
Pasquale Vergara
,
Savino Altizio
,
Giulio Falasconi
,
et al
Added:
2 years ago
Author(s):
Megan Barber
,
Jason Chinitz
,
Roy John
Added:
3 years ago
Ventricular arrhythmias are designated idiopathic when demonstrable structural heart disease, significant coronary disease including coronary spasm or genetic arrhythmia syndromes are absent.1 These arrhythmias may be benign but are also a recognised cause of sudden cardiac death. The common form of idiopathic ventricular tachycardia (VT) originates in the ventricular outflow tracts, manifest…
View more
The Role of Cardiac MRI in the Diagnosis and Risk Stratification of Hypertrophic Cardiomyopathy
Author(s):
Ethan J Rowin
,
Martin S Maron
Added:
3 years ago
Article
Author(s):
Eyal Nof
,
William G Stevenson
,
Roy John
Added:
3 years ago
Sustained ventricular tachycardia (VT) and ventricular fibrillation (VF) are typically a manifestation of significant structural heart disease and often associated with a high risk of sudden cardiac death. Implantable cardioverter defibrillators (ICDs) remain the mainstay of therapy for prevention of sudden cardiac death associated with these arrhythmias.1 However, ICDs treat the arrhythmia after…
View more
Author(s):
Jorge G Panizo
,
Sergio Barra
,
Greg Mellor
,
et al
Added:
3 years ago
Premature ventricular complexes (PVCs) are the most common ventricular arrhythmia. Their prognostic significance cannot be interpreted without considering the presence or absence of any associated underlying cardiac condition. In the absence of structural heart disease, PVCs were generally considered to be benign.1,2 In the 1970s and 1980s, it was postulated that frequent PVCs could be a trigger…
View more
Author(s):
Venkatesh Ravi
,
Jeffrey Winterfield
,
Jackson J Liang
,
et al
Added:
1 year ago
Author(s):
Sebastiaan RD Piers
,
Katja Zeppenfeld
Added:
3 years ago
Over the last 20 years ventricular tachycardia (VT) ablation has evolved from a treatment modality for selected patients withrecurrent haemodynamically tolerated VT (which can be mapped during ongoing arrhythmia), to a therapeutic option for patients with tolerated and untolerated VT using substrate-based ablation strategies.1 The substrate for VT after myocardial infarction (MI) consists of…
View more
Author(s):
Eun-Jeong Kim
,
Giovanni Davogustto
,
William G Stevenson
,
et al
Added:
3 years ago
Myocardial scars from infarction or replacement fibrosis in non-ischaemic cardiomyopathies are the common substrate for sustained monomorphic ventricular tachycardia (VT).1,2 In selected patients at high risk of ventricular arrhythmias, placement of an implantable cardioverter-defibrillator (ICD) is effective for prevention of sudden cardiac death.2 Although ICDs are effective in terminating VT…
View more
Author(s):
Adam J Graham
,
Michele Orini
,
Pier D Lambiase
Added:
3 years ago
Recurrent episodes of ventricular tachycardia (VT) in patients with structural heart disease are associated with increased mortality and morbidity, despite the life-saving benefits of implantable cardiac defibrillators (ICDs).1,2 Because ICD therapies are abortive and do not alter the underlying arrhythmogenic substrate, their reduction becomes important, especially as recurrent shocks can cause…
View more